[go: up one dir, main page]

DE60320766D1 - Synthese von indolthiazolverbindungen als liganden des ah-rezeptors - Google Patents

Synthese von indolthiazolverbindungen als liganden des ah-rezeptors

Info

Publication number
DE60320766D1
DE60320766D1 DE60320766T DE60320766T DE60320766D1 DE 60320766 D1 DE60320766 D1 DE 60320766D1 DE 60320766 T DE60320766 T DE 60320766T DE 60320766 T DE60320766 T DE 60320766T DE 60320766 D1 DE60320766 D1 DE 60320766D1
Authority
DE
Germany
Prior art keywords
synthesis
indolothiazole
ligands
receptor
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60320766T
Other languages
English (en)
Inventor
Hector F Deluca
Pawel K Grzywacz
Rafal R Sicinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/074,102 external-priority patent/US6916834B2/en
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of DE60320766D1 publication Critical patent/DE60320766D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE60320766T 2002-02-12 2003-02-11 Synthese von indolthiazolverbindungen als liganden des ah-rezeptors Expired - Fee Related DE60320766D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35658502P 2002-02-12 2002-02-12
US10/074,102 US6916834B2 (en) 2001-02-14 2002-02-12 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester
PCT/US2003/004205 WO2003068742A1 (en) 2002-02-12 2003-02-11 Synthesis of indole thiazole compounds as ligands for the ah receptor

Publications (1)

Publication Number Publication Date
DE60320766D1 true DE60320766D1 (de) 2008-06-19

Family

ID=27736819

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60320766T Expired - Fee Related DE60320766D1 (de) 2002-02-12 2003-02-11 Synthese von indolthiazolverbindungen als liganden des ah-rezeptors

Country Status (10)

Country Link
US (2) US7002019B2 (de)
EP (1) EP1480951B1 (de)
JP (1) JP4445266B2 (de)
CN (2) CN1642910A (de)
AT (1) ATE394373T1 (de)
AU (1) AU2003209130B2 (de)
CA (1) CA2475331C (de)
DE (1) DE60320766D1 (de)
MX (1) MXPA04007767A (de)
WO (1) WO2003068742A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207689A (pt) * 2001-02-14 2004-03-09 Wisconsin Alumni Res Found Preparação, e, método de preparação de ligando de receptor de ah endógeno
WO2003000253A1 (en) 2001-06-20 2003-01-03 Wyeth Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
DE60320766D1 (de) * 2002-02-12 2008-06-19 Wisconsin Alumni Res Found Synthese von indolthiazolverbindungen als liganden des ah-rezeptors
DE60327550D1 (de) * 2002-12-10 2009-06-18 Wyeth Corp Substituierte indoloxoacetylaminoessigsäurederivate als inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
WO2004052855A2 (en) 2002-12-10 2004-06-24 Wyeth Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
CA2509170A1 (en) 2002-12-10 2004-06-24 Wyeth Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
ES2314289T3 (es) 2002-12-10 2009-03-16 Wyeth Derivados del acido 1h-indol-3-il glioxilico sustituidos con arilo, ariloxi y alquloxi como inhibidores del inhibidor del activador del plasminogeno-1(pai-1).
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
US7230133B2 (en) 2003-05-01 2007-06-12 Bristol-Myers Squibb Company Malonamides and malonamide derivatives as modulators of chemokine receptor activity
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
BRPI0514544A (pt) 2004-08-23 2008-06-17 Wyeth Corp ácidos de oxazol-naftila como moduladores de inibidor tipo-1 de ativador de plasminogênio (pai-1)
MX2007002177A (es) 2004-08-23 2007-04-02 Wyeth Corp Acidos de pirrolo-naftilo como inhibidores de pai-1.
EP1794138A2 (de) 2004-08-23 2007-06-13 Wyeth Thiazolo-naphthylsäuren als inhibitoren von plasminogen-aktivator-inhibitor-1
MX2008002117A (es) 2005-08-17 2008-09-26 Wyeth Corp Indoles sustituidos y metodos de uso de estos.
EP2082736A1 (de) * 2008-01-23 2009-07-29 Jean Hilaire Saurat Pharmazeutische Zusammensetzung zur lokalen Anwendung
US8236849B2 (en) * 2008-10-15 2012-08-07 Ohio Northern University Model for glutamate racemase inhibitors and glutamate racemase antibacterial agents
US10632106B2 (en) 2009-11-02 2020-04-28 Ariagen, Inc. Methods of cancer treatment with 2-(1′H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester
AU2010313622B2 (en) 2009-11-02 2014-08-14 Ahr Pharmaceuticals, Inc. ITE for cancer intervention and eradication
CN102775399A (zh) * 2011-12-27 2012-11-14 盛世泰科生物医药技术(苏州)有限公司 arylhydrocarbon受体(AHR)的内源性配体,2-(1’H3’-吲哚羰基)噻唑-4-羧酸甲酯的合成新方法
US10711106B2 (en) * 2013-07-25 2020-07-14 The University Of Chicago High aspect ratio nanofibril materials
JP6665188B2 (ja) * 2014-09-12 2020-03-13 エイエイチアール ファーマシューティカルズ インコーポレイテッド 2−(1’h−インドール−3’−カルボニル)−チアゾール−4−カルボン酸メチルエステル及びその構造的類似体の効率的且つスケーラブルな合成
CN108239083B (zh) 2016-12-26 2021-08-17 阿里根公司 芳香烃受体调节剂
CN111587249A (zh) 2017-11-20 2020-08-25 阿里根公司 吲哚化合物及其用途
EP3956327A1 (de) 2019-04-15 2022-02-23 Ariagen, Inc. Chirale indolverbindungen und deren verwendung
US11136318B2 (en) 2019-06-21 2021-10-05 Noramco, Llc Processes for the preparation of aryl hydrocarbon receptor ligands

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265931A (en) * 1964-09-21 1966-08-09 Martin E Gerry Magnetic ignition distributor
US3285931A (en) 1964-12-21 1966-11-15 Union Carbide Corp Preparation of substituted pyrrole derivatives
US5366685A (en) 1989-07-18 1994-11-22 Idemitsu Petrochemical Co., Ltd. Process of molding thermoplastic sheet by plug assist vacuum forming
US6323228B1 (en) 2000-09-15 2001-11-27 Abbott Laboratories 3-substituted indole angiogenesis inhibitors
US6523228B1 (en) * 2000-10-26 2003-02-25 Avery Dennison Corporation Tamper-proof tie
BR0207689A (pt) * 2001-02-14 2004-03-09 Wisconsin Alumni Res Found Preparação, e, método de preparação de ligando de receptor de ah endógeno
EP1427413A2 (de) * 2001-09-13 2004-06-16 Synta Pharmaceuticals Corporation 2-aroylimidazol-verbindungen zur behandlung von krebs
DE60320766D1 (de) * 2002-02-12 2008-06-19 Wisconsin Alumni Res Found Synthese von indolthiazolverbindungen als liganden des ah-rezeptors

Also Published As

Publication number Publication date
US20060079692A1 (en) 2006-04-13
EP1480951A4 (de) 2006-03-22
CN1915991A (zh) 2007-02-21
US20040204588A1 (en) 2004-10-14
US7002019B2 (en) 2006-02-21
MXPA04007767A (es) 2004-10-15
US7241900B2 (en) 2007-07-10
JP4445266B2 (ja) 2010-04-07
ATE394373T1 (de) 2008-05-15
CN1915991B (zh) 2010-05-26
AU2003209130B2 (en) 2008-06-05
CN1642910A (zh) 2005-07-20
JP2005525340A (ja) 2005-08-25
EP1480951B1 (de) 2008-05-07
CA2475331A1 (en) 2003-08-21
AU2003209130A1 (en) 2003-09-04
EP1480951A1 (de) 2004-12-01
WO2003068742A1 (en) 2003-08-21
CA2475331C (en) 2012-06-12

Similar Documents

Publication Publication Date Title
DE60320766D1 (de) Synthese von indolthiazolverbindungen als liganden des ah-rezeptors
DE60041584D1 (de) Substituierte oxoazaheterozyclische verbindungen
EA200600925A1 (ru) Производные триазола в качестве антагонистов вазопрессина
NO20093402L (no) Framgangsmate for syntetisering av camptothesin relaterte forbindelser
RS20050380A (en) 3-amino piperidine derivatives and methods of manufacture
ATE452882T1 (de) Herstellung von quetiapin
NO20060219L (no) Forbindelser
DE50306845D1 (de) Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide
GB0129476D0 (en) Organic compounds
NO982850L (no) Ny syntese
GB0031103D0 (en) Chemical compounds
HUP0102723A2 (hu) Új difenilkarbamid-származékok, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
TR200100698T2 (tr) 5-HT4 alıcı-Antagonistleri olarak Dihidrobenzodioksin Karboksamit ve Keton türevleri
DE50010886D1 (de) Neue cyclopropane als cgrp-antagonisten, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
MX2007004637A (es) Sintesis asimetrica de derivados de dihidrobenzofurano.
ATE429429T1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
ATE453389T1 (de) Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
EP1555261A4 (de) Valerolactonverbindungen und parf mzusammensetzung
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
WO2005000804A3 (en) Substituted indoles and a process for preparing substituted indoles
ATE257831T1 (de) Synthese von wasserlöslischem 9-dihydroplacitaxel derivate aus 9-dihydro-13-acetylbacchatin iii
IS7181A (is) Aralkýl-tetrahýdró-pýridín, framleiðsla þeirra oglyfjasamsetningar sem innihalda þau
WO2004039776A3 (en) A process for the preparation of benzyl 2-oxo-4- (heteroaryl) dithio-alpha-isoprenyl-1- azetidineazetate derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee